Nurix Therapeutics is trading 5.3% down at $23.80 in after-hours trading with no clear catalyst, slipping from a regular-session close of $25.12.
- There is currently no fresh company-specific news, earnings release, or major announcement tied to the move.
- The decline likely reflects typical after-hours volatility and order-flow dynamics as liquidity thins out.